Amid persistent global headwinds—ranging from geopolitical risks to evolving trade and tariff dynamics—project ramp-up delays and discretionary spend rationalization by clients continue to weigh on near-term growth visibility. Factoring in these recent developments, the brokerage reduces Tata Elxsi's FY26E/FY27E EPS by 4.0% each to Rs 142.3/ Rs 169.8 respectively.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
DRChoksey Report
Tata Elxsi Ltd.’s Q4 FY25 performance was below expectations, with weakness across transportation—impacted by OEM-led program deferrals— and media, which remained under pressure from client restructuring and cautious R&D spending. The healthcare segment, however, showed sequential recovery, supported by traction in digital engineering and recent client additions.
Strategically, the company secured three large multi-year deals, including a €50 million SDV engagement and a $100+ million, three-year consolidation contract in media, which are expected to drive annuity revenue from FY26E. It also marked its entry into the aerospace and defense vertical, with initial revenue contributions anticipated in FY26E.
Amid persistent global headwinds—ranging from geopolitical risks to evolving trade and tariff dynamics—project ramp-up delays and discretionary spend rationalization by clients continue to weigh on near-term growth visibility.
Factoring in these recent developments, we reduce our FY26E/FY27E EPS by 4.0% each to Rs 142.3/ Rs 169.8 respectively.
We value Tata Elxi at a lower P/E multiple of 30.0x (earlier: 33.0x), implying a target price of Rs 5,093. Although, the ramp-up of recent large deals and Tata Elxsi’s strategic pivot toward OEMs and SDV-focused engagements is likely to support revenue stability ahead, we believe the stock is fairly valued.
Accordingly, we downgrade our rating to “Hold” from “Reduce” and maintain a cautious stance pending greater visibility on margin normalization and macro recovery.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Metals, Mining Q1 Results Review— Inline Show; Tata Steel, JSW Steel, NMDC Among Systematix' Top Picks


Motilal Oswal Initiates Coverage On These Three IT Stocks With Buy And Sell Rating


Ashok Leyland Stock Q1 Review — Nirmal Bang Maintains 'Buy', Says Margins To Expand On Better Mix, Pricing


HUL Q1 Results Review: Systematix Maintains 'Hold', Hikes Target Price — Here's Why
